摘要 |
The invention relates to a compound having general formula (I), wherein: R represents a hydrogen atom or a vinyl group; n represents 0, 1 or 2; X represents a groups having formula CH or a nitrogen atom; R1 represents a phenyl or naphthyl group, or a cyclohexyl group, or a heteroaryl group; R2 represents a hydrogen atom, or one or more substituents selected from among the halogen atoms and the trifluoromethyl, alkyl, alkoxy, thienyl, phenyloxy, hydroxy, mercapto, thioalkyl, cyano groups or a group having general formula -NR4R5, SO2NR4R5, -SO2-alkyl, -SO2-phenyl, -CONR4R5, -COOR7, -CO-alkyl, -CO-phenyl, -NHCOR8, -NHSO2-alkyl, -NHSO2-phenyl and -NHSO2NR4R5 or a divalent group having formula -OCF2O-; and R4 and R5 each represent a hydrogen atom or an alkyl group or R4 and R5, together with the nitrogen atom bearing same, form a pyrrolidine, piperidine or morpholine ring. The invention also relates to the use of said compound in therapeutics. |
申请人 |
SANOFI-AVENTIS;DARGAZANLI, GIHAD;ESTENNE-BOUHTOU, GENEVIEVE;MAGAT, PASCALE;MARABOUT, BENOIT;ROGER, PIERRE |
发明人 |
DARGAZANLI, GIHAD;ESTENNE-BOUHTOU, GENEVIEVE;MAGAT, PASCALE;MARABOUT, BENOIT;ROGER, PIERRE |